Back
Jones Lang LaSalle, Inc. Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison
Buy
78
JLL
Jones Lang LaSalle, Inc.
Last Price:
$352.82
Seasonality Move:
9.23%
Buy
70
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$52.50
Seasonality Move:
69.73%
Buy
78
Jones Lang LaSalle, Inc. (JLL)
is a Buy
Is Jones Lang LaSalle, Inc. a Buy, Sell or Hold?
-
The current Jones Lang LaSalle, Inc. [JLL] share price is $352.72. The Score for JLL is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
JLL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Regencell Bioscience Holdings Ltd. (RGC)
is a Buy
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $52.88. The Score for RGC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JLL Stock Price Chart
What is Jones Lang LaSalle, Inc.'s stock price today?
-
The Jones Lang LaSalle, Inc. share price today is $352.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JLL is experiencing slight selling pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $52.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
JLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.28 | Buy |
| Relative Strength Index (14 RSI): | 68.11 | Buy |
| Chaikin Money Flow: | -70124 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (327.81 - 344.69) | Buy |
| Bollinger Bands (100): | (295.46 - 329.34) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.21 | Buy |
| Relative Strength Index (14 RSI): | 87.06 | Buy |
| Chaikin Money Flow: | 2558033 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.04 - 28.92) | Buy |
| Bollinger Bands (100): | (11.09 - 21.37) | Buy |
JLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 343.99 | Buy |
| 20-day SMA: | 338.86 | Buy |
| 50-day SMA: | 321.58 | Buy |
| 200-day SMA: | 277.3 | Buy |
| 8-day EMA: | 345.24 | Buy |
| 20-day EMA: | 338.64 | Buy |
| 50-day EMA: | 325.89 | Buy |
| 200-day EMA: | 290.81 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.75 | Buy |
| 20-day SMA: | 22.49 | Buy |
| 50-day SMA: | 17.26 | Buy |
| 200-day SMA: | 14.27 | Buy |
| 8-day EMA: | 31.19 | Buy |
| 20-day EMA: | 24.47 | Buy |
| 50-day EMA: | 19.59 | Buy |
| 200-day EMA: | 13.98 | Buy |
Jones Lang LaSalle, Inc. Earnings Growth & JLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.98 per share, and an increase next year of $2.86 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Jones Lang LaSalle, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||